Placeholder product image

PT-141

PT-141 (Bremelanotide) is a centrally acting peptide designed to support sexual desire, arousal, and intimacy by working directly on the brain’s melanocortin receptors rather than through hormonal or vascular pathways. Unlike medications that rely on blood flow or testosterone levels, PT-141 targets the neural pathways involved in sexual motivation and responsiveness. This makes it a versatile option for individuals seeking to improve libido, arousal, and sexual satisfaction, regardless of hormone levels or gender.

Medical Grade99+ PurityMade in the USAFDA Certified Facility

Select Size:

Potential benefits may include:

  • Enhances sexual desire and arousal
  • Supports improved sexual responsiveness and satisfaction
  • May increase libido independent of hormone levels
  • Supports sexual confidence and intimacy
  • Can be effective for both men and women
  • Designed for use before sexual activity, with flexibility to take only when needed
  • Pregnancy or Breastfeeding: Safety has not been established; use is not recommended.
  • Uncontrolled Hypertension or Cardiovascular Disease: Use only under medical supervision, as PT-141 may temporarily raise blood pressure.
  • Known Allergy: Avoid use if you have a sensitivity to PT-141 or formulation components.
  • Severe Nausea Sensitivity or Migraine Disorders: Use with caution and provider guidance, as nausea or headache may occur in some individuals.

PT-141 is generally well tolerated when used as directed, but mild, short-term side effects may occur, especially with initial use or higher doses. These may include:

  • Nausea (most common side effect), usually dose-dependent and short-lived
  • Flushing or warmth of the face or body
  • Mild headache or light dizziness
  • Temporary increase in blood pressure
  • Injection site redness, tenderness, or irritation

These effects are typically mild and resolve on their own as the medication wears off. Starting with a lower dose and gradually adjusting can help minimize side effects, particularly nausea.

For safe and informed use, review the Extension Health Injection Reaction Guide (PDF), which outlines what to expect, how to reduce discomfort, and when to seek medical support.

  • 30–60 Minutes: Initial effects may begin as PT-141 activates melanocortin receptors in the brain. Some patients notice subtle arousal, warmth, flushing, or a mental shift toward desire and openness to intimacy.
  • 1–4 Hours: Peak effects are typically observed during this window. Patients may experience increased sexual interest, stronger arousal, improved sensitivity, and enhanced sexual responsiveness. Men often report more reliable erectile response, while women commonly notice heightened arousal, responsiveness, and overall satisfaction.
  • Up to 12 Hours: Benefits gradually taper but may last for several hours, sometimes extending into the next day at a lower intensity. Many patients report increased confidence, reduced performance anxiety, and a more relaxed experience around intimacy.
  • Long-Term (As-Needed Use): With consistent, as-needed use, PT-141 can help restore sexual confidence, improve intimacy and relationship satisfaction, and provide a reliable on-demand option for managing recurrent issues with low libido or arousal, without the need for daily dosing or hormonal manipulation.